BioHealth News
GEN: Top 50 NIH-Funded Institutions of 2024
By Alex Philippidis - September 26, 2024 As Congress wrangles over a budget for the 2025 federal fiscal year, which begins October 1, the NIH will be paying…
Read More
New NIH Research Awards Support Community-Led Research to Reduce Health Disparities
The NIH Common Fund is funding five new research awards to Health Equity Research Hubs that will support community-led research projects. These awards total…
Read More
Tagworks Pharmaceuticals Appoints Ken Mills as Chief Executive Officer
NIJMEGEN, Netherlands and BOSTON, Oct. 1, 2024 /PRNewswire/ -- Tagworks Pharmaceuticals BV ("Tagworks"), a precision oncology company using its proprietary Click-to-Release treatment platform to develop a new standard of care for…
Read More
Emergent BioSolutions Announces Closing of $100 Million Asset-Backed Loan Facility
GAITHERSBURG, Md., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it entered into a new credit agreement on September 30, 2024 providing for an…
Read More
Children’s National, Additional Ventures announce finalists in pediatric medical device competition
WASHINGTON, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Ten medical technology innovators focused on pediatric cardiology have been selected to compete for $300,000 in grants…
Read More
BioBridges’ Expands Services with Dedicated MedTech Division
Morrisville, NC – September 25, 2024– BioBridges, a leading provider of people and technology solutions for the life sciences industry, announces the launch of…
Read More
IPWatchdog LIVE 2024
Join us for our Fourth Annual IPWatchdog LIVE Conference Bringing together the intellectual property community – from politicos, to business executives, to attorneys, and…
Read More
Gaithersburg’s Altimmune Completes Enrollment in Phase 2b IMPACT Trial of Pemvidutide in Metabolic Dysfunction-Associated Steatohepatitis (MASH)
GAITHERSBURG, Md., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced completion of patient enrollment in IMPACT, its Phase…
Read More
WBJ: Children’s National lands $35M gift to advance prenatal, neonatal treatment
By Alan Kline – Senior Editor, Washington Business Journal - Sep 26, 2024 - Children’s National Hospital has landed another large gift from the government of…
Read More
Emergent BioSolutions Announces the Execution of Contract Options Valued at $67.4 Million to Procure Additional TEMBEXA® (brincidofovir) to Support National Preparedness Efforts
GAITHERSBURG, Md., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) (“Emergent”) today announced that two contract options have been secured to procure additional treatment…
Read More
miRecule Showcases Innovative RNA Therapies this week at RESI Boston 2024
At RESI Boston 2024, held on September 25th at the Westin Copley Place, Montgomery County-based biotechnology company miRecule, a client of BioHealth Innovation Inc.…
Read More
NIH Awards Sonavex $2 Million Grant to Conduct Clinical Trial and Seek Regulatory Clearance of EchoGuide
EchoGuide is Sonavex’s pipeline product designed to improve cannulation for dialysis patients. Baltimore, MD (September 25th, 2024) – Sonavex, Inc., a privately held medical…
Read More
Gaithersburg’s Georgiamune Announces First Participant Dosed in First-In-Class Phase 1 Healthy Volunteers Trial of GIM-407
GAITHERSBURG, Md., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Today, Georgiamune Inc., a privately held, clinical-stage biotechnology company, announced that the first participant has been dosed…
Read More
Maryland Governor Wes Moore Addresses BioHealth Capital Region Forum at USP
The BioHealth Capital Region Forum had the honor of hosting Maryland Governor Wes Moore, who addressed attendees at the 10th Annual event held at…
Read More
Keynotes and Presenters Drive the Conversation at BioHealth Capital Region Forum
The 10th Annual BioHealth Capital Region Forum has once again brought together some of the most influential leaders and innovators in the biohealth industry.…
Read More